SML3983
BAY 2686013
≥98% (HPLC)
Synonym(s):
2-amino-N-(4-((3,5-bis(trifluoromethyl)benzyl)oxy)phenyl)acetamide hydrochloride
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C(CN)NC(C=C1)=CC=C1OCC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2.Cl
Biochem/physiol Actions
Orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
BAY 2686013 is an orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
BAY 2686013 is an orally available, potent and selective allosteric antagonist of the human pituitary adenylate cyclase activating polypeptide receptor (hPAC1-R).
Caution
Hygroscopic
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Molecular pharmacology, 104(3), 105-114 (2023-06-23)
The human pituitary adenylate cyclase-activating polypeptide receptor (hPAC1-R), a class B G-protein-coupled receptor (GPCR) identified almost 30 years ago, represents an important pharmacological target in the areas of neuroscience, oncology, and immunology. Despite interest in this target, only a very
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service